PSL Develops Microsphere Refiner for Formulation of Microspheres

News
Article

PSL has developed a microsphere refiner for microsphere formulation, from small scale processes to commercial production.

PSL, a manufacturer of filtration, drying and complete containment solutions, announced that it has developed a microsphere refiner for microsphere formulation. There is a high demand for microsphere production within the pharmaceutical industry. Formulation methods are usually developed by laboratory development contract organisations and research universities. The PSL microsphere refiner offers unique filtration solutions for microsphere formulation, from small scale processes to commercial production.

Microspheres are small spherical particles, typically ranging from 5 microns up to 250 microns. The particles are manufactured from various natural and synthetic materials such as polymer microspheres. The biodegradable polymer microspheres can work as miniature time-release capsules for parenteral drugs.

Suspended microspheres obtained from various microencapsulation processes require unique handling that is different from a typical filtration and drying operation. After the synthesis stage, microspheres must be washed, classified by size, filtered and dried under appropriate conditions to gain the final free-flowing injectable or inhalation microsphere product. PSL microsphere refiners have been designed to meet these criteria from washing to classifying and drying. Size classification, considered the most difficult step in microspheres production, can be achieved with PSL’s unique design, which utilises side and bottom filtration.

Microsphere processes generally involve handling large liquid volumes with a small ratio of suspended solids. Some processes would therefore require a scalping prefiltration step to reduce the liquid volume and eliminate the oversized microspheres. This can achieved with the PSL scalping filter prior to transfer into the PSL microsphere refiner. PSL stated in its press release that several projects have been completed using the company’s microsphere filtration solutions from laboratory scale to commercial production.

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content